Theratechnologies To Make Oral Presentation On Oncology Platform During AACR Virtual Annual Meeting

Apr 16, 2020
PDF Version
Supporting Materials:
Montreal, Canada – April 16, 2020 – Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that it will make an oral presentation on new results from its sortilin targeting oncology platform during a virtual session of the annual meeting of the American Association for Cancer Research (AACR).